Point72 Hong Kong’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,155
Closed -$118K 1843
2022
Q3
$118K Sell
12,155
-424
-3% -$4.12K ﹤0.01% 1185
2022
Q2
$122K Hold
12,579
﹤0.01% 1115
2022
Q1
$122K Hold
12,579
﹤0.01% 1103
2021
Q4
$123K Sell
12,579
-188
-1% -$1.84K ﹤0.01% 1133
2021
Q3
$125K Buy
+12,767
New +$126K ﹤0.01% 1285

Other funds holding DALS

Point72 Hong Kong's DALS Position: Q4 2022 in Review

Point72 Hong Kong sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q4 2022, closing a stake of 12,155 shares — an estimated $118K sold.

Point72 Hong Kong first reported a position in DALS in Q3 2021 and held it in 5 quarters. The position peaked at $125K in Q3 2021. 47 funds tracked by Wall St. Rank hold DALS as of Q4 2022.

  • Point72 Hong Kong reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 12,155 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $118K.
  • Point72 Hong Kong first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q3 2021 and held it in 5 quarters.
  • Point72 Hong Kong's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $125K in Q3 2021.
  • 47 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.